Table of Content

1 Study Coverage

1.1 Vaccine Excipients Product Introduction

1.2 Market by Type

1.2.1 Global Vaccine Excipients Market Size Growth Rate by Type, 2018 VS 2022 VS 2029

1.2.2 Vaccine Stabilizers

1.2.3 Vaccine Emulsifiers

1.2.4 Vaccine Adjuvants

1.2.5 Preservatives

1.3 Market by Application

1.3.1 Global Vaccine Excipients Market Size Growth Rate by Application, 2018 VS 2022 VS 2029

1.3.2 Research Applications

1.3.3 Commercial Applications

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Vaccine Excipients Sales Estimates and Forecasts 2018-2029

2.2 Global Vaccine Excipients Revenue by Region

2.2.1 Global Vaccine Excipients Revenue by Region: 2018 VS 2022 VS 2029

2.2.2 Global Vaccine Excipients Revenue by Region (2018-2024)

2.2.3 Global Vaccine Excipients Revenue by Region (2024-2029)

2.2.4 Global Vaccine Excipients Revenue Market Share by Region (2018-2029)

2.3 Global Vaccine Excipients Sales Estimates and Forecasts 2018-2029

2.4 Global Vaccine Excipients Sales by Region

2.4.1 Global Vaccine Excipients Sales by Region: 2018 VS 2022 VS 2029

2.4.2 Global Vaccine Excipients Sales by Region (2018-2024)

2.4.3 Global Vaccine Excipients Sales by Region (2024-2029)

2.4.4 Global Vaccine Excipients Sales Market Share by Region (2018-2029)

2.5 US & Canada

2.6 Europe

2.7 China

2.8 Asia (excluding China)

2.9 Middle East, Africa and Latin America

3 Competition by Manufactures

3.1 Global Vaccine Excipients Sales by Manufacturers

3.1.1 Global Vaccine Excipients Sales by Manufacturers (2018-2024)

3.1.2 Global Vaccine Excipients Sales Market Share by Manufacturers (2018-2024)

3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine Excipients in 2022

3.2 Global Vaccine Excipients Revenue by Manufacturers

3.2.1 Global Vaccine Excipients Revenue by Manufacturers (2018-2024)

3.2.2 Global Vaccine Excipients Revenue Market Share by Manufacturers (2018-2024)

3.2.3 Global Top 10 and Top 5 Companies by Vaccine Excipients Revenue in 2022

3.3 Global Key Players of Vaccine Excipients, Industry Ranking, 2021 VS 2022 VS 2024

3.4 Global Vaccine Excipients Sales Price by Manufacturers

3.5 Analysis of Competitive Landscape

3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

3.5.2 Global Vaccine Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.6 Global Key Manufacturers of Vaccine Excipients, Manufacturing Base Distribution and Headquarters

3.7 Global Key Manufacturers of Vaccine Excipients, Product Offered and Application

3.8 Global Key Manufacturers of Vaccine Excipients, Date of Enter into This Industry

3.9 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

4.1 Global Vaccine Excipients Sales by Type

4.1.1 Global Vaccine Excipients Historical Sales by Type (2018-2024)

4.1.2 Global Vaccine Excipients Forecasted Sales by Type (2024-2029)

4.1.3 Global Vaccine Excipients Sales Market Share by Type (2018-2029)

4.2 Global Vaccine Excipients Revenue by Type

4.2.1 Global Vaccine Excipients Historical Revenue by Type (2018-2024)

4.2.2 Global Vaccine Excipients Forecasted Revenue by Type (2024-2029)

4.2.3 Global Vaccine Excipients Revenue Market Share by Type (2018-2029)

4.3 Global Vaccine Excipients Price by Type

4.3.1 Global Vaccine Excipients Price by Type (2018-2024)

4.3.2 Global Vaccine Excipients Price Forecast by Type (2024-2029)

5 Market Size by Application

5.1 Global Vaccine Excipients Sales by Application

5.1.1 Global Vaccine Excipients Historical Sales by Application (2018-2024)

5.1.2 Global Vaccine Excipients Forecasted Sales by Application (2024-2029)

5.1.3 Global Vaccine Excipients Sales Market Share by Application (2018-2029)

5.2 Global Vaccine Excipients Revenue by Application

5.2.1 Global Vaccine Excipients Historical Revenue by Application (2018-2024)

5.2.2 Global Vaccine Excipients Forecasted Revenue by Application (2024-2029)

5.2.3 Global Vaccine Excipients Revenue Market Share by Application (2018-2029)

5.3 Global Vaccine Excipients Price by Application

5.3.1 Global Vaccine Excipients Price by Application (2018-2024)

5.3.2 Global Vaccine Excipients Price Forecast by Application (2024-2029)

6 US & Canada

6.1 US & Canada Vaccine Excipients Market Size by Type

6.1.1 US & Canada Vaccine Excipients Sales by Type (2018-2029)

6.1.2 US & Canada Vaccine Excipients Revenue by Type (2018-2029)

6.2 US & Canada Vaccine Excipients Market Size by Application

6.2.1 US & Canada Vaccine Excipients Sales by Application (2018-2029)

6.2.2 US & Canada Vaccine Excipients Revenue by Application (2018-2029)

6.3 US & Canada Vaccine Excipients Market Size by Country

6.3.1 US & Canada Vaccine Excipients Revenue by Country: 2018 VS 2022 VS 2029

6.3.2 US & Canada Vaccine Excipients Sales by Country (2018-2029)

6.3.3 US & Canada Vaccine Excipients Revenue by Country (2018-2029)

6.3.4 US

6.3.5 Canada

7 Europe

7.1 Europe Vaccine Excipients Market Size by Type

7.1.1 Europe Vaccine Excipients Sales by Type (2018-2029)

7.1.2 Europe Vaccine Excipients Revenue by Type (2018-2029)

7.2 Europe Vaccine Excipients Market Size by Application

7.2.1 Europe Vaccine Excipients Sales by Application (2018-2029)

7.2.2 Europe Vaccine Excipients Revenue by Application (2018-2029)

7.3 Europe Vaccine Excipients Market Size by Country

7.3.1 Europe Vaccine Excipients Revenue by Country: 2018 VS 2022 VS 2029

7.3.2 Europe Vaccine Excipients Sales by Country (2018-2029)

7.3.3 Europe Vaccine Excipients Revenue by Country (2018-2029)

7.3.4 Germany

7.3.5 France

7.3.6 U.K.

7.3.7 Italy

7.3.8 Russia

8 China

8.1 China Vaccine Excipients Market Size

8.1.1 China Vaccine Excipients Sales (2018-2029)

8.1.2 China Vaccine Excipients Revenue (2018-2029)

8.2 China Vaccine Excipients Market Size by Application

8.2.1 China Vaccine Excipients Sales by Application (2018-2029)

8.2.2 China Vaccine Excipients Revenue by Application (2018-2029)

9 Asia (excluding China)

9.1 Asia Vaccine Excipients Market Size by Type

9.1.1 Asia Vaccine Excipients Sales by Type (2018-2029)

9.1.2 Asia Vaccine Excipients Revenue by Type (2018-2029)

9.2 Asia Vaccine Excipients Market Size by Application

9.2.1 Asia Vaccine Excipients Sales by Application (2018-2029)

9.2.2 Asia Vaccine Excipients Revenue by Application (2018-2029)

9.3 Asia Vaccine Excipients Sales by Region

9.3.1 Asia Vaccine Excipients Revenue by Region: 2018 VS 2022 VS 2029

9.3.2 Asia Vaccine Excipients Revenue by Region (2018-2029)

9.3.3 Asia Vaccine Excipients Sales by Region (2018-2029)

9.3.4 Japan

9.3.5 South Korea

9.3.6 China Taiwan

9.3.7 Southeast Asia

9.3.8 India

10 Middle East, Africa and Latin America

10.1 Middle East, Africa and Latin America Vaccine Excipients Market Size by Type

10.1.1 Middle East, Africa and Latin America Vaccine Excipients Sales by Type (2018-2029)

10.1.2 Middle East, Africa and Latin America Vaccine Excipients Revenue by Type (2018-2029)

10.2 Middle East, Africa and Latin America Vaccine Excipients Market Size by Application

10.2.1 Middle East, Africa and Latin America Vaccine Excipients Sales by Application (2018-2029)

10.2.2 Middle East, Africa and Latin America Vaccine Excipients Revenue by Application (2018-2029)

10.3 Middle East, Africa and Latin America Vaccine Excipients Sales by Country

10.3.1 Middle East, Africa and Latin America Vaccine Excipients Revenue by Country: 2018 VS 2022 VS 2029

10.3.2 Middle East, Africa and Latin America Vaccine Excipients Revenue by Country (2018-2029)

10.3.3 Middle East, Africa and Latin America Vaccine Excipients Sales by Country (2018-2029)

10.3.4 Brazil

10.3.5 Mexico

10.3.6 Turkey

10.3.7 Israel

10.3.8 GCC Countries

11 Company Profiles

11.1 Curia

11.1.1 Curia Company Information

11.1.2 Curia Overview

11.1.3 Curia Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.1.4 Curia Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.1.5 Curia Recent Developments

11.2 Croda Pharma

11.2.1 Croda Pharma Company Information

11.2.2 Croda Pharma Overview

11.2.3 Croda Pharma Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.2.4 Croda Pharma Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.2.5 Croda Pharma Recent Developments

11.3 Alfa Chemistry

11.3.1 Alfa Chemistry Company Information

11.3.2 Alfa Chemistry Overview

11.3.3 Alfa Chemistry Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.3.4 Alfa Chemistry Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.3.5 Alfa Chemistry Recent Developments

11.4 A & C

11.4.1 A & C Company Information

11.4.2 A & C Overview

11.4.3 A & C Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.4.4 A & C Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.4.5 A & C Recent Developments

11.5 Avantor

11.5.1 Avantor Company Information

11.5.2 Avantor Overview

11.5.3 Avantor Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.5.4 Avantor Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.5.5 Avantor Recent Developments

11.6 GS

11.6.1 GS Company Information

11.6.2 GS Overview

11.6.3 GS Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.6.4 GS Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.6.5 GS Recent Developments

11.7 SEPPIC

11.7.1 SEPPIC Company Information

11.7.2 SEPPIC Overview

11.7.3 SEPPIC Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.7.4 SEPPIC Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.7.5 SEPPIC Recent Developments

11.8 Novavax

11.8.1 Novavax Company Information

11.8.2 Novavax Overview

11.8.3 Novavax Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.8.4 Novavax Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.8.5 Novavax Recent Developments

11.9 Dynavax Technologies

11.9.1 Dynavax Technologies Company Information

11.9.2 Dynavax Technologies Overview

11.9.3 Dynavax Technologies Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.9.4 Dynavax Technologies Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.9.5 Dynavax Technologies Recent Developments

11.10 Sanofi

11.10.1 Sanofi Company Information

11.10.2 Sanofi Overview

11.10.3 Sanofi Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.10.4 Sanofi Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.10.5 Sanofi Recent Developments

11.11 Zhifei Biological

11.11.1 Zhifei Biological Company Information

11.11.2 Zhifei Biological Overview

11.11.3 Zhifei Biological Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.11.4 Zhifei Biological Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.11.5 Zhifei Biological Recent Developments

11.12 Escon

11.12.1 Escon Company Information

11.12.2 Escon Overview

11.12.3 Escon Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.12.4 Escon Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.12.5 Escon Recent Developments

11.13 Rico Bio

11.13.1 Rico Bio Company Information

11.13.2 Rico Bio Overview

11.13.3 Rico Bio Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.13.4 Rico Bio Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.13.5 Rico Bio Recent Developments

11.14 CSL Limited

11.14.1 CSL Limited Company Information

11.14.2 CSL Limited Overview

11.14.3 CSL Limited Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.14.4 CSL Limited Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.14.5 CSL Limited Recent Developments

11.15 Creative Biolabs

11.15.1 Creative Biolabs Company Information

11.15.2 Creative Biolabs Overview

11.15.3 Creative Biolabs Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.15.4 Creative Biolabs Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.15.5 Creative Biolabs Recent Developments

11.16 Central Drug House

11.16.1 Central Drug House Company Information

11.16.2 Central Drug House Overview

11.16.3 Central Drug House Vaccine Excipients Sales, Price, Revenue and Gross Margin (2018-2024)

11.16.4 Central Drug House Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

11.16.5 Central Drug House Recent Developments

12 Industry Chain and Sales Channels Analysis

12.1 Vaccine Excipients Industry Chain Analysis

12.2 Vaccine Excipients Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Vaccine Excipients Production Mode & Process

12.4 Vaccine Excipients Sales and Marketing

12.4.1 Vaccine Excipients Sales Channels

12.4.2 Vaccine Excipients Distributors

12.5 Vaccine Excipients Customers

13 Market Dynamics

13.1 Vaccine Excipients Industry Trends

13.2 Vaccine Excipients Market Drivers

13.3 Vaccine Excipients Market Challenges

13.4 Vaccine Excipients Market Restraints

14 Key Findings in The Global Vaccine Excipients Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.2 Data Source

15.2 Author Details

15.3 Disclaimer

List of Figure

List of Tables

Table 1. Global Vaccine Excipients Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Table 2. Major Manufacturers of Vaccine Stabilizers

Table 3. Major Manufacturers of Vaccine Emulsifiers

Table 4. Major Manufacturers of Vaccine Adjuvants

Table 5. Major Manufacturers of Preservatives

Table 6. Global Vaccine Excipients Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Table 7. Global Vaccine Excipients Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 8. Global Vaccine Excipients Revenue by Region (2018-2024) & (US$ Million)

Table 9. Global Vaccine Excipients Revenue by Region (2024-2029) & (US$ Million)

Table 10. Global Vaccine Excipients Revenue Market Share by Region (2018-2024)

Table 11. Global Vaccine Excipients Revenue Market Share by Region (2024-2029)

Table 12. Global Vaccine Excipients Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)

Table 13. Global Vaccine Excipients Sales by Region (2018-2024) & (kg)

Table 14. Global Vaccine Excipients Sales by Region (2024-2029) & (kg)

Table 15. Global Vaccine Excipients Sales Market Share by Region (2018-2024)

Table 16. Global Vaccine Excipients Sales Market Share by Region (2024-2029)

Table 17. Global Vaccine Excipients Sales by Manufacturers (2018-2024) & (kg)

Table 18. Global Vaccine Excipients Sales Share by Manufacturers (2018-2024)

Table 19. Global Vaccine Excipients Revenue by Manufacturers (2018-2024) & (US$ Million)

Table 20. Global Vaccine Excipients Revenue Share by Manufacturers (2018-2024)

Table 21. Global Key Players of Vaccine Excipients, Industry Ranking, 2021 VS 2022 VS 2024

Table 22. Vaccine Excipients Price by Manufacturers 2018-2024 (US$/g)

Table 23. Global Vaccine Excipients Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 24. Global Vaccine Excipients by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Excipients as of 2022)

Table 25. Global Key Manufacturers of Vaccine Excipients, Manufacturing Base Distribution and Headquarters

Table 26. Global Key Manufacturers of Vaccine Excipients, Product Offered and Application

Table 27. Global Key Manufacturers of Vaccine Excipients, Date of Enter into This Industry

Table 28. Mergers & Acquisitions, Expansion Plans

Table 29. Global Vaccine Excipients Sales by Type (2018-2024) & (kg)

Table 30. Global Vaccine Excipients Sales by Type (2024-2029) & (kg)

Table 31. Global Vaccine Excipients Sales Share by Type (2018-2024)

Table 32. Global Vaccine Excipients Sales Share by Type (2024-2029)

Table 33. Global Vaccine Excipients Revenue by Type (2018-2024) & (US$ Million)

Table 34. Global Vaccine Excipients Revenue by Type (2024-2029) & (US$ Million)

Table 35. Global Vaccine Excipients Revenue Share by Type (2018-2024)

Table 36. Global Vaccine Excipients Revenue Share by Type (2024-2029)

Table 37. Vaccine Excipients Price by Type (2018-2024) & (US$/g)

Table 38. Global Vaccine Excipients Price Forecast by Type (2024-2029) & (US$/g)

Table 39. Global Vaccine Excipients Sales by Application (2018-2024) & (kg)

Table 40. Global Vaccine Excipients Sales by Application (2024-2029) & (kg)

Table 41. Global Vaccine Excipients Sales Share by Application (2018-2024)

Table 42. Global Vaccine Excipients Sales Share by Application (2024-2029)

Table 43. Global Vaccine Excipients Revenue by Application (2018-2024) & (US$ Million)

Table 44. Global Vaccine Excipients Revenue by Application (2024-2029) & (US$ Million)

Table 45. Global Vaccine Excipients Revenue Share by Application (2018-2024)

Table 46. Global Vaccine Excipients Revenue Share by Application (2024-2029)

Table 47. Vaccine Excipients Price by Application (2018-2024) & (US$/g)

Table 48. Global Vaccine Excipients Price Forecast by Application (2024-2029) & (US$/g)

Table 49. US & Canada Vaccine Excipients Sales by Type (2018-2024) & (kg)

Table 50. US & Canada Vaccine Excipients Sales by Type (2024-2029) & (kg)

Table 51. US & Canada Vaccine Excipients Revenue by Type (2018-2024) & (US$ Million)

Table 52. US & Canada Vaccine Excipients Revenue by Type (2024-2029) & (US$ Million)

Table 53. US & Canada Vaccine Excipients Sales by Application (2018-2024) & (kg)

Table 54. US & Canada Vaccine Excipients Sales by Application (2024-2029) & (kg)

Table 55. US & Canada Vaccine Excipients Revenue by Application (2018-2024) & (US$ Million)

Table 56. US & Canada Vaccine Excipients Revenue by Application (2024-2029) & (US$ Million)

Table 57. US & Canada Vaccine Excipients Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 58. US & Canada Vaccine Excipients Revenue by Country (2018-2024) & (US$ Million)

Table 59. US & Canada Vaccine Excipients Revenue by Country (2024-2029) & (US$ Million)

Table 60. US & Canada Vaccine Excipients Sales by Country (2018-2024) & (kg)

Table 61. US & Canada Vaccine Excipients Sales by Country (2024-2029) & (kg)

Table 62. Europe Vaccine Excipients Sales by Type (2018-2024) & (kg)

Table 63. Europe Vaccine Excipients Sales by Type (2024-2029) & (kg)

Table 64. Europe Vaccine Excipients Revenue by Type (2018-2024) & (US$ Million)

Table 65. Europe Vaccine Excipients Revenue by Type (2024-2029) & (US$ Million)

Table 66. Europe Vaccine Excipients Sales by Application (2018-2024) & (kg)

Table 67. Europe Vaccine Excipients Sales by Application (2024-2029) & (kg)

Table 68. Europe Vaccine Excipients Revenue by Application (2018-2024) & (US$ Million)

Table 69. Europe Vaccine Excipients Revenue by Application (2024-2029) & (US$ Million)

Table 70. Europe Vaccine Excipients Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 71. Europe Vaccine Excipients Revenue by Country (2018-2024) & (US$ Million)

Table 72. Europe Vaccine Excipients Revenue by Country (2024-2029) & (US$ Million)

Table 73. Europe Vaccine Excipients Sales by Country (2018-2024) & (kg)

Table 74. Europe Vaccine Excipients Sales by Country (2024-2029) & (kg)

Table 75. China Vaccine Excipients Sales by Type (2018-2024) & (kg)

Table 76. China Vaccine Excipients Sales by Type (2024-2029) & (kg)

Table 77. China Vaccine Excipients Revenue by Type (2018-2024) & (US$ Million)

Table 78. China Vaccine Excipients Revenue by Type (2024-2029) & (US$ Million)

Table 79. China Vaccine Excipients Sales by Application (2018-2024) & (kg)

Table 80. China Vaccine Excipients Sales by Application (2024-2029) & (kg)

Table 81. China Vaccine Excipients Revenue by Application (2018-2024) & (US$ Million)

Table 82. China Vaccine Excipients Revenue by Application (2024-2029) & (US$ Million)

Table 83. Asia Vaccine Excipients Sales by Type (2018-2024) & (kg)

Table 84. Asia Vaccine Excipients Sales by Type (2024-2029) & (kg)

Table 85. Asia Vaccine Excipients Revenue by Type (2018-2024) & (US$ Million)

Table 86. Asia Vaccine Excipients Revenue by Type (2024-2029) & (US$ Million)

Table 87. Asia Vaccine Excipients Sales by Application (2018-2024) & (kg)

Table 88. Asia Vaccine Excipients Sales by Application (2024-2029) & (kg)

Table 89. Asia Vaccine Excipients Revenue by Application (2018-2024) & (US$ Million)

Table 90. Asia Vaccine Excipients Revenue by Application (2024-2029) & (US$ Million)

Table 91. Asia Vaccine Excipients Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 92. Asia Vaccine Excipients Revenue by Region (2018-2024) & (US$ Million)

Table 93. Asia Vaccine Excipients Revenue by Region (2024-2029) & (US$ Million)

Table 94. Asia Vaccine Excipients Sales by Region (2018-2024) & (kg)

Table 95. Asia Vaccine Excipients Sales by Region (2024-2029) & (kg)

Table 96. Middle East, Africa and Latin America Vaccine Excipients Sales by Type (2018-2024) & (kg)

Table 97. Middle East, Africa and Latin America Vaccine Excipients Sales by Type (2024-2029) & (kg)

Table 98. Middle East, Africa and Latin America Vaccine Excipients Revenue by Type (2018-2024) & (US$ Million)

Table 99. Middle East, Africa and Latin America Vaccine Excipients Revenue by Type (2024-2029) & (US$ Million)

Table 100. Middle East, Africa and Latin America Vaccine Excipients Sales by Application (2018-2024) & (kg)

Table 101. Middle East, Africa and Latin America Vaccine Excipients Sales by Application (2024-2029) & (kg)

Table 102. Middle East, Africa and Latin America Vaccine Excipients Revenue by Application (2018-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Vaccine Excipients Revenue by Application (2024-2029) & (US$ Million)

Table 104. Middle East, Africa and Latin America Vaccine Excipients Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)

Table 105. Middle East, Africa and Latin America Vaccine Excipients Revenue by Country (2018-2024) & (US$ Million)

Table 106. Middle East, Africa and Latin America Vaccine Excipients Revenue by Country (2024-2029) & (US$ Million)

Table 107. Middle East, Africa and Latin America Vaccine Excipients Sales by Country (2018-2024) & (kg)

Table 108. Middle East, Africa and Latin America Vaccine Excipients Sales by Country (2024-2029) & (kg)

Table 109. Curia Company Information

Table 110. Curia Description and Major Businesses

Table 111. Curia Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 112. Curia Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 113. Curia Recent Developments

Table 114. Croda Pharma Company Information

Table 115. Croda Pharma Description and Major Businesses

Table 116. Croda Pharma Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 117. Croda Pharma Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 118. Croda Pharma Recent Developments

Table 119. Alfa Chemistry Company Information

Table 120. Alfa Chemistry Description and Major Businesses

Table 121. Alfa Chemistry Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 122. Alfa Chemistry Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 123. Alfa Chemistry Recent Developments

Table 124. A & C Company Information

Table 125. A & C Description and Major Businesses

Table 126. A & C Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 127. A & C Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 128. A & C Recent Developments

Table 129. Avantor Company Information

Table 130. Avantor Description and Major Businesses

Table 131. Avantor Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 132. Avantor Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 133. Avantor Recent Developments

Table 134. GS Company Information

Table 135. GS Description and Major Businesses

Table 136. GS Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 137. GS Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 138. GS Recent Developments

Table 139. SEPPIC Company Information

Table 140. SEPPIC Description and Major Businesses

Table 141. SEPPIC Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 142. SEPPIC Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 143. SEPPIC Recent Developments

Table 144. Novavax Company Information

Table 145. Novavax Description and Major Businesses

Table 146. Novavax Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 147. Novavax Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 148. Novavax Recent Developments

Table 149. Dynavax Technologies Company Information

Table 150. Dynavax Technologies Description and Major Businesses

Table 151. Dynavax Technologies Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 152. Dynavax Technologies Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 153. Dynavax Technologies Recent Developments

Table 154. Sanofi Company Information

Table 155. Sanofi Description and Major Businesses

Table 156. Sanofi Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 157. Sanofi Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 158. Sanofi Recent Developments

Table 159. Zhifei Biological Company Information

Table 160. Zhifei Biological Description and Major Businesses

Table 161. Zhifei Biological Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 162. Zhifei Biological Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 163. Zhifei Biological Recent Developments

Table 164. Escon Company Information

Table 165. Escon Description and Major Businesses

Table 166. Escon Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 167. Escon Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 168. Escon Recent Developments

Table 169. Rico Bio Company Information

Table 170. Rico Bio Description and Major Businesses

Table 171. Rico Bio Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 172. Rico Bio Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 173. Rico Bio Recent Developments

Table 174. CSL Limited Company Information

Table 175. CSL Limited Description and Major Businesses

Table 176. CSL Limited Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 177. CSL Limited Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 178. CSL Limited Recent Developments

Table 179. Creative Biolabs Company Information

Table 180. Creative Biolabs Description and Major Businesses

Table 181. Creative Biolabs Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 182. Creative Biolabs Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 183. Creative Biolabs Recent Developments

Table 184. Central Drug House Company Information

Table 185. Central Drug House Description and Major Businesses

Table 186. Central Drug House Vaccine Excipients Sales (kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2018-2024)

Table 187. Central Drug House Vaccine Excipients Product Model Numbers, Pictures, Descriptions and Specifications

Table 188. Central Drug House Recent Developments

Table 189. Key Raw Materials Lists

Table 190. Raw Materials Key Suppliers Lists

Table 191. Vaccine Excipients Distributors List

Table 192. Vaccine Excipients Customers List

Table 193. Vaccine Excipients Market Trends

Table 194. Vaccine Excipients Market Drivers

Table 195. Vaccine Excipients Market Challenges

Table 196. Vaccine Excipients Market Restraints

Table 197. Research Programs/Design for This Report

Table 198. Key Data Information from Secondary Sources

Table 199. Key Data Information from Primary Sources

List of Figures

Figure 1. Vaccine Excipients Product Picture

Figure 2. Global Vaccine Excipients Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)

Figure 3. Global Vaccine Excipients Market Share by Type in 2022 & 2029

Figure 4. Vaccine Stabilizers Product Picture

Figure 5. Vaccine Emulsifiers Product Picture

Figure 6. Vaccine Adjuvants Product Picture

Figure 7. Preservatives Product Picture

Figure 8. Global Vaccine Excipients Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)

Figure 9. Global Vaccine Excipients Market Share by Application in 2022 & 2029

Figure 10. Research Applications

Figure 11. Commercial Applications

Figure 12. Vaccine Excipients Report Years Considered

Figure 13. Global Vaccine Excipients Revenue, (US$ Million), 2018 VS 2022 VS 2029

Figure 14. Global Vaccine Excipients Revenue 2018-2029 (US$ Million)

Figure 15. Global Vaccine Excipients Revenue Market Share by Region in Percentage: 2022 Versus 2029

Figure 16. Global Vaccine Excipients Revenue Market Share by Region (2018-2029)

Figure 17. Global Vaccine Excipients Sales 2018-2029 ((kg)

Figure 18. Global Vaccine Excipients Sales Market Share by Region (2018-2029)

Figure 19. US & Canada Vaccine Excipients Sales YoY (2018-2029) & (kg)

Figure 20. US & Canada Vaccine Excipients Revenue YoY (2018-2029) & (US$ Million)

Figure 21. Europe Vaccine Excipients Sales YoY (2018-2029) & (kg)

Figure 22. Europe Vaccine Excipients Revenue YoY (2018-2029) & (US$ Million)

Figure 23. China Vaccine Excipients Sales YoY (2018-2029) & (kg)

Figure 24. China Vaccine Excipients Revenue YoY (2018-2029) & (US$ Million)

Figure 25. Asia (excluding China) Vaccine Excipients Sales YoY (2018-2029) & (kg)

Figure 26. Asia (excluding China) Vaccine Excipients Revenue YoY (2018-2029) & (US$ Million)

Figure 27. Middle East, Africa and Latin America Vaccine Excipients Sales YoY (2018-2029) & (kg)

Figure 28. Middle East, Africa and Latin America Vaccine Excipients Revenue YoY (2018-2029) & (US$ Million)

Figure 29. The Vaccine Excipients Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022

Figure 30. The Top 5 and 10 Largest Manufacturers of Vaccine Excipients in the World: Market Share by Vaccine Excipients Revenue in 2022

Figure 31. Global Vaccine Excipients Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022

Figure 32. Global Vaccine Excipients Sales Market Share by Type (2018-2029)

Figure 33. Global Vaccine Excipients Revenue Market Share by Type (2018-2029)

Figure 34. Global Vaccine Excipients Sales Market Share by Application (2018-2029)

Figure 35. Global Vaccine Excipients Revenue Market Share by Application (2018-2029)

Figure 36. US & Canada Vaccine Excipients Sales Market Share by Type (2018-2029)

Figure 37. US & Canada Vaccine Excipients Revenue Market Share by Type (2018-2029)

Figure 38. US & Canada Vaccine Excipients Sales Market Share by Application (2018-2029)

Figure 39. US & Canada Vaccine Excipients Revenue Market Share by Application (2018-2029)

Figure 40. US & Canada Vaccine Excipients Revenue Share by Country (2018-2029)

Figure 41. US & Canada Vaccine Excipients Sales Share by Country (2018-2029)

Figure 42. U.S. Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 43. Canada Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 44. Europe Vaccine Excipients Sales Market Share by Type (2018-2029)

Figure 45. Europe Vaccine Excipients Revenue Market Share by Type (2018-2029)

Figure 46. Europe Vaccine Excipients Sales Market Share by Application (2018-2029)

Figure 47. Europe Vaccine Excipients Revenue Market Share by Application (2018-2029)

Figure 48. Europe Vaccine Excipients Revenue Share by Country (2018-2029)

Figure 49. Europe Vaccine Excipients Sales Share by Country (2018-2029)

Figure 50. Germany Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 51. France Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 52. U.K. Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 53. Italy Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 54. Russia Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 55. China Vaccine Excipients Sales Market Share by Type (2018-2029)

Figure 56. China Vaccine Excipients Revenue Market Share by Type (2018-2029)

Figure 57. China Vaccine Excipients Sales Market Share by Application (2018-2029)

Figure 58. China Vaccine Excipients Revenue Market Share by Application (2018-2029)

Figure 59. Asia Vaccine Excipients Sales Market Share by Type (2018-2029)

Figure 60. Asia Vaccine Excipients Revenue Market Share by Type (2018-2029)

Figure 61. Asia Vaccine Excipients Sales Market Share by Application (2018-2029)

Figure 62. Asia Vaccine Excipients Revenue Market Share by Application (2018-2029)

Figure 63. Asia Vaccine Excipients Revenue Share by Region (2018-2029)

Figure 64. Asia Vaccine Excipients Sales Share by Region (2018-2029)

Figure 65. Japan Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 66. South Korea Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 67. China Taiwan Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 68. Southeast Asia Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 69. India Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 70. Middle East, Africa and Latin America Vaccine Excipients Sales Market Share by Type (2018-2029)

Figure 71. Middle East, Africa and Latin America Vaccine Excipients Revenue Market Share by Type (2018-2029)

Figure 72. Middle East, Africa and Latin America Vaccine Excipients Sales Market Share by Application (2018-2029)

Figure 73. Middle East, Africa and Latin America Vaccine Excipients Revenue Market Share by Application (2018-2029)

Figure 74. Middle East, Africa and Latin America Vaccine Excipients Revenue Share by Country (2018-2029)

Figure 75. Middle East, Africa and Latin America Vaccine Excipients Sales Share by Country (2018-2029)

Figure 76. Brazil Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 77. Mexico Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 78. Turkey Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 79. Israel Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 80. GCC Countries Vaccine Excipients Revenue (2018-2029) & (US$ Million)

Figure 81. Vaccine Excipients Value Chain

Figure 82. Vaccine Excipients Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed